ArticleFrontiers in oncology2026
Resources are associated with functional outcome and brain morphometry in childhood cancer survivors.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Childhood cancer survivors exhibit a high prevalence of long-term cognitive and motor impairments as well as structural brain alterations. Examining late effects from a multimodal perspective is essential as individual and contextual resources (e.g. self-efficacy, optimism; parental support, socioeconomic status) as well as risk factors (e.g. disease and treatment related factors) likely impact neurodevelopment such as functional outcome (cognition, motor function) and brain structure in childhood cancer survivors. It is purely understood how individual and contextual resources are associated with functional outcome and brain structure and whether resources can moderate the relationship between functional outcome and brain structure. A deeper understanding of these interrelations can help to identify components for multimodal interventions to strengthen neurodevelopment after childhood cancer in the long-term. This exploratory study investigates associations between resources (individual and contextual) and neurodevelopmental outcomes and how resources moderate functional outcome, and brain morphometry in childhood cancer survivors. Methods: 56 childhood cancer survivors (N = 45 non central nervous system cancer survivors (non-CNS), N = 11 CNS cancer survivors (CNS)) and 45 typically developing children all aged 7-16 years; M = 10.85, SD = 2.52)) underwent structural MRI, cognitive and motor assessments and filled out questionnaires on individual and contextual resources at least one year after the end of cancer treatment. Correlations were computed, followed by principal components analysis to minimize factors (given the small sample and number of variables), and subsequent moderation analyses were conducted. Results: More and stronger correlations occurred between resources and functional outcome as well as resources and brain morphometry in survivors (non-CNS: N correlations = 16, r = 0.32-0.61; CNS: N correlation = 9, r = 0.78-0.97) compared with typically developing children (N correlation = 2, r = 0.34-0.37), with the strongest effects in CNS cancer survivors. Interaction effects suggest that resources may moderate the associations between cognition and motor function (β=-0.834-0.894, p Conclusion: These exploratory findings propose that individual and contextual resources are associated with functional outcome and brain morphometry following childhood cancer, suggesting that resource-oriented, multimodal interventions should be considered for neurodevelopmental rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.